NCT02549625View on ClinicalTrials.gov

Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Congenital Heart Disease
Interventions
BIOLOGICAL

Autologous Bone Marrow-derived Mononuclear Cells

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

Timothy J Nelson, MD, PhD

OTHER